Literature DB >> 20663885

PKA-induced receptor activator of NF-kappaB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification.

Wendy Tseng1, Lucia S Graham, Yifan Geng, Aneela Reddy, Jinxiu Lu, Rita B Effros, Linda Demer, Yin Tintut.   

Abstract

Vascular calcification is a predictor of cardiovascular mortality and is prevalent in patients with atherosclerosis and chronic renal disease. It resembles skeletal osteogenesis, and many bone cells as well as bone-related factors involved in both formation and resorption have been localized in calcified arteries. Previously, we showed that aortic medial cells undergo osteoblastic differentiation and matrix calcification both spontaneously and in response to PKA agonists. The PKA signaling pathway is also involved in regulating bone resorption in skeletal tissue by stimulating osteoblast-production of osteoclast regulating cytokines, including receptor-activator of nuclear κB ligand (RANKL) and interleukins. Therefore, we investigated whether PKA activators regulate osteoclastogenesis in aortic smooth muscle cells (SMC). Treatment of murine SMC with the PKA agonist forskolin stimulated RANKL expression at both mRNA and protein levels. Forskolin also stimulated expression of interleukin-6 but not osteoprotegerin (OPG), an inhibitor of RANKL. Consistent with these results, osteoclastic differentiation was induced when monocytic preosteoclasts (RAW264.7) were cocultured with forskolin-treated aortic SMC. Oxidized phospholipids also slightly induced RANKL expression in T lymphocytes, another potential source of RANKL in the vasculature. Because previous studies have shown that RANKL treatment alone induces matrix calcification of valvular and vascular cells, we next examined whether RANKL mediates forskolin-induced matrix calcification by aortic SMC. RANKL inhibition with OPG had little or no effect on osteoblastic differentiation and matrix calcification of aortic SMC. These findings suggest that, as in skeletal tissues, PKA activation induces bone resorptive factors in the vasculature and that aortic SMC calcification specifically induced by PKA, is not mediated by RANKL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663885      PMCID: PMC2943298          DOI: 10.1074/jbc.M110.117366

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

2.  Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin.

Authors:  Chartrisa LaShan Simpson; Suzanne Lindley; Carol Eisenberg; Dina M Basalyga; Barry C Starcher; Dan T Simionescu; Narendra R Vyavahare
Journal:  Cardiovasc Pathol       Date:  2007 Jan-Feb       Impact factor: 2.185

3.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

4.  Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway.

Authors:  Y Tintut; J Patel; F Parhami; L L Demer
Journal:  Circulation       Date:  2000-11-21       Impact factor: 29.690

5.  cAMP/PKA signaling inhibits osteogenic differentiation and bone formation in rodent models.

Authors:  Ramakrishnaiah Siddappa; Winfried Mulder; Ilse Steeghs; Christine van de Klundert; Hugo Fernandes; Jun Liu; Roel Arends; Clemens van Blitterswijk; Jan de Boer
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

6.  Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss.

Authors:  Lucia S Graham; Farhad Parhami; Yin Tintut; Christina M R Kitchen; Linda L Demer; Rita B Effros
Journal:  Clin Immunol       Date:  2009-08-22       Impact factor: 3.969

7.  High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells.

Authors:  Anaïs Mozar; Nathalie Haren; Maud Chasseraud; Loïc Louvet; Cécile Mazière; Alice Wattel; Romuald Mentaverri; Patrice Morlière; Saïd Kamel; Michel Brazier; Jean C Mazière; Ziad A Massy
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

8.  RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.

Authors:  Sara Panizo; Anna Cardus; Mario Encinas; Eva Parisi; Petya Valcheva; Susana López-Ongil; Blai Coll; Elvira Fernandez; Jose M Valdivielso
Journal:  Circ Res       Date:  2009-03-26       Impact factor: 17.367

9.  Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification.

Authors:  Michael S Huang; Andrew P Sage; Jinxiu Lu; Linda L Demer; Yin Tintut
Journal:  Biochem Biophys Res Commun       Date:  2008-07-23       Impact factor: 3.575

10.  Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries.

Authors:  Mei Y Speer; Hsueh-Ying Yang; Thea Brabb; Elizabeth Leaf; Amy Look; Wei-Ling Lin; Andrew Frutkin; David Dichek; Cecilia M Giachelli
Journal:  Circ Res       Date:  2009-02-05       Impact factor: 17.367

View more
  15 in total

1.  Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice.

Authors:  S Morony; A P Sage; T Corbin; J Lu; Y Tintut; L L Demer
Journal:  Calcif Tissue Int       Date:  2012-10-09       Impact factor: 4.333

2.  Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice.

Authors:  Sohel Shamsuzzaman; Melda Onal; Hillary C St John; J Wesley Pike
Journal:  J Cell Biochem       Date:  2017-05-30       Impact factor: 4.429

3.  The leading edge of vascular calcification.

Authors:  Linda L Demer; Yin Tintut
Journal:  Trends Cardiovasc Med       Date:  2014-12-03       Impact factor: 6.677

4.  CR6-interacting factor-1 contributes to osteoclastogenesis by inducing receptor activator of nuclear factor κB ligand after radiation.

Authors:  Li-Xin Xiang; Qian Ran; Li Chen; Yang Xiang; Feng-Jie Li; Xiao-Mei Zhang; Yan-Ni Xiao; Ling-Yun Zou; Jiang F Zhong; Shengwen Calvin Li; Zhong-Jun Li
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

Review 5.  Where do we stand on vascular calcification?

Authors:  Kristina I Boström
Journal:  Vascul Pharmacol       Date:  2016-05-31       Impact factor: 5.773

6.  RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α.

Authors:  Kate Ann Deuell; Andrea Callegari; Cecilia M Giachelli; Michael E Rosenfeld; Marta Scatena
Journal:  J Vasc Res       Date:  2012-08-30       Impact factor: 1.934

7.  Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signaling.

Authors:  Florante R Ricarte; Carole Le Henaff; Victoria G Kolupaeva; Thomas J Gardella; Nicola C Partridge
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

8.  Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.

Authors:  Andrea Callegari; Matthew L Coons; Jerry L Ricks; Michael E Rosenfeld; Marta Scatena
Journal:  J Vasc Res       Date:  2014-03-07       Impact factor: 1.934

9.  The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy.

Authors:  Agbor Ndip; Alfred Williams; Edward B Jude; Ferdinand Serracino-Inglott; Steve Richardson; J V Smyth; Andrew J M Boulton; M Yvonne Alexander
Journal:  Diabetes       Date:  2011-06-09       Impact factor: 9.461

10.  Distribution of alkaline phosphatase, osteopontin, RANK ligand and osteoprotegerin in calcified human carotid atheroma.

Authors:  Catherine L Higgins; Salim Isbilir; Pamela Basto; Iou Yih Chen; Muthiah Vaduganathan; Periyanan Vaduganathan; Michael J Reardon; Gerald Lawrie; Leif Peterson; Joel D Morrisett
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.